YU96075A - Process for the manufacture of thienyl and thiethyl compounds - Google Patents

Process for the manufacture of thienyl and thiethyl compounds

Info

Publication number
YU96075A
YU96075A YU00960/75A YU96075A YU96075A YU 96075 A YU96075 A YU 96075A YU 00960/75 A YU00960/75 A YU 00960/75A YU 96075 A YU96075 A YU 96075A YU 96075 A YU96075 A YU 96075A
Authority
YU
Yugoslavia
Prior art keywords
thiethyl
thienyl
compounds
manufacture
thiethyl compounds
Prior art date
Application number
YU00960/75A
Other languages
English (en)
Inventor
Aldrich Paul Edward
Paul Edward Aldrich
Berezin Gilbert Harvey
Gilbert Harvey Berezin
Dittmar Bruce Ivor
Bruce Ivor Dittmar
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of YU96075A publication Critical patent/YU96075A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D331/00Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04Four-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
YU00960/75A 1974-04-17 1975-04-16 Process for the manufacture of thienyl and thiethyl compounds YU96075A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46169974A 1974-04-17 1974-04-17
US05/555,307 US4009847A (en) 1974-04-17 1975-03-11 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Publications (1)

Publication Number Publication Date
YU96075A true YU96075A (en) 1983-04-27

Family

ID=27040095

Family Applications (1)

Application Number Title Priority Date Filing Date
YU00960/75A YU96075A (en) 1974-04-17 1975-04-16 Process for the manufacture of thienyl and thiethyl compounds

Country Status (21)

Country Link
US (1) US4009847A (fi)
JP (1) JPS50148349A (fi)
AR (1) AR208545A1 (fi)
CA (1) CA1047042A (fi)
CH (1) CH611292A5 (fi)
DD (1) DD117223A5 (fi)
DE (1) DE2516554A1 (fi)
DK (1) DK164175A (fi)
ES (1) ES436648A1 (fi)
FI (1) FI751128A (fi)
FR (1) FR2267773B1 (fi)
GB (1) GB1461209A (fi)
HU (1) HU173052B (fi)
IE (1) IE41143B1 (fi)
IL (1) IL47095A (fi)
LU (1) LU72306A1 (fi)
NL (1) NL7504570A (fi)
NO (1) NO144071C (fi)
PH (1) PH11722A (fi)
SE (1) SE417965B (fi)
YU (1) YU96075A (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156738A (en) * 1977-10-07 1979-05-29 E. I. Du Pont De Nemours And Company Ureidonitriles useful as antihypertensives
US6344476B1 (en) 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US6187799B1 (en) * 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
ATE556713T1 (de) * 1999-01-13 2012-05-15 Bayer Healthcare Llc Omega-carboxyarylsubstituierte-diphenyl- harnstoffe als p38-kinasehemmer
RU2319693C9 (ru) 1999-01-13 2008-08-20 Байер Копэрейшн Производные мочевины (варианты), фармацевтическая композиция (варианты) и способ лечения заболевания, связанного с ростом раковых клеток (варианты)
WO2000042012A1 (en) 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
US8124630B2 (en) * 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
ES2275931T5 (es) * 2001-12-03 2018-10-23 Bayer Healthcare Llc Compuestos de aril-urea en combinación con otros agentes citostáticos o citotóxicos para tratamiento de cánceres humanos
US20080108672A1 (en) * 2002-01-11 2008-05-08 Bernd Riedl Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
SI1478358T1 (sl) * 2002-02-11 2013-09-30 Bayer Healthcare Llc Sorafenib tozilat za zdravljenje bolezni, značilnih po abnormalni angiogenezi
WO2003068223A1 (en) * 2002-02-11 2003-08-21 Bayer Corporation Aryl ureas with raf kinase and angiogenesis inhibiting activity
WO2003068229A1 (en) * 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
CA2475818C (en) * 2002-02-11 2011-07-19 Bayer Pharmaceuticals Corporation Aryl ureas as kinase inhibitors
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
PT1626714E (pt) * 2003-05-20 2007-08-24 Bayer Pharmaceuticals Corp Diarilureias para doenças mediadas por pdgfr
EA010485B1 (ru) * 2003-07-23 2008-10-30 Байер Фамэсьютиклс Копэрейшн Производное n,n'-дифенилмочевины, фармацевтическая композиция (варианты) и способ лечения и предупреждения заболеваний и состояний с его использованием (варианты)
WO2005110994A2 (en) * 2004-04-30 2005-11-24 Bayer Pharmaceuticals Corporation Substituted pyrazolyl urea derivatives useful in the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH452475A (de) * 1965-05-20 1968-05-31 Bayer Ag Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen

Also Published As

Publication number Publication date
NL7504570A (nl) 1975-10-21
HU173052B (hu) 1979-02-28
AR208545A1 (es) 1977-02-15
GB1461209A (en) 1977-01-13
FI751128A (fi) 1975-10-18
DK164175A (da) 1975-10-18
CA1047042A (en) 1979-01-23
PH11722A (en) 1978-05-30
DD117223A5 (fi) 1976-01-05
CH611292A5 (fi) 1979-05-31
IL47095A0 (en) 1975-06-25
SE7503523L (sv) 1975-10-20
NO144071C (no) 1981-06-17
SE417965B (sv) 1981-04-27
IE41143L (en) 1975-10-17
DE2516554A1 (de) 1975-10-30
JPS50148349A (fi) 1975-11-27
IL47095A (en) 1978-03-10
NO144071B (no) 1981-03-09
LU72306A1 (fi) 1976-03-17
NO751351L (fi) 1975-10-20
ES436648A1 (es) 1977-08-01
FR2267773B1 (fi) 1978-08-18
FR2267773A1 (fi) 1975-11-14
IE41143B1 (en) 1979-10-24
US4009847A (en) 1977-03-01
AU8013575A (en) 1976-10-21

Similar Documents

Publication Publication Date Title
YU96075A (en) Process for the manufacture of thienyl and thiethyl compounds
GB1520798A (en) Process for the production of 2 - aryl - 2h - benzotriazoles
GB1538869A (en) D-homo-20-keto-pregnanes and process for their manufacture
IL47770A0 (en) 18-methyl-19-nor-20-keto-pregnanes and process for their manufacture
JPS51115446A (en) Ppbenzoquinone diketals and process for manufacture thereof
ZA757745B (en) Process for the production of carbonylaldiminomethanephosphonates
YU39471B (en) Process for the manufactue of new 1-thiazolylimidazolidinones
IL48062A0 (en) Process for the preparation of metasubstituted halogenophenols
CH613683A5 (en) Process for the preparation of secoprostaglandins
AU8138475A (en) New thiophene derivatives and process for their manufacture
EG11784A (en) Process for the preparation of octenitrile compounds and compounds obtained thereby
ZA757523B (en) Process for the production of jodophors
HK66380A (en) 1,3-dithiol-2-ylidene malonic esters, process for preparing the same, and use of said esters
IL47317A0 (en) New thiophene derivatives and process for their manufacture
JPS52244A (en) Process for manufacture of pseudotrisaccharides
ZA75976B (en) Process for the preparation of cis-vincamine
CH612932A5 (en) Process for the preparation of alkylsulphonylphenoxy-propanolamines
YU96275A (en) Process for the manufacture of furyl compounds
ZA752986B (en) Process for the manufacture of new heterocyclic s-imino-s-oxides
AU8123075A (en) New pyrrol derivatives and process for the manufacture of these compounds
ZA755931B (en) Process for the manufacture of aluminiumchloride
GB1518104A (en) Process for the preparation of 2-hydrocarbylglycerols
IL47243A0 (en) Process for the preparation of 4-hydroxypyrimidines
CH613693A5 (en) Process for the preparation of trisaminopyridines
IL48633A (en) Process for the preparation of trichlorothiazole